CIK 0001506983 · Non-accelerated filer<br>Smaller reporting company
Glucotrack, Inc.
Sign in to watch- Ticker
- GCTK
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980668934
- Phone
- 972 (8) 675-7878
- Business address
- 301 RT 17 NORTH, SUITE 800, RUTHERFORD, NJ, 07070
- Former names
- Integrity Applications, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-12 | John A. Ballantyne Revocable Living Trust dated 08/01/2017 10% owner | Option exercise · Series B Common Warrant | −132,036 | 0 | ||
| 2025-03-12 | BALLANTYNE JOHN Director | Option exercise | +2,560,553 | 2,743,591 | ||
| 2025-03-12 | BALLANTYNE JOHN Director | Option exercise · Series B Common Warrant | −132,036 | 0 | ||
| 2025-03-12 | Malave Luis Director | Option exercise | +133,532 | 141,541 | ||
| 2025-03-12 | Malave Luis Director | Option exercise · Series B Common Warrant | −6,886 | 0 | ||
| 2025-03-12 | Carter Erin Catherine Director | Option exercise | +40,297 | 43,736 | ||
| 2025-03-12 | Carter Erin Catherine Director | Option exercise · Series B Common Warrant | −2,078 | 0 | ||
| 2025-03-12 | Goode Paul Chief Executive Officer | Option exercise | +15,435 | 18,989 | ||
| 2025-03-12 | Goode Paul Chief Executive Officer | Option exercise · Series B Common Warrant | +796 | 0 | ||
| 2025-02-05 | Goode Paul Chief Executive Officer | Other acquisition | +1,500 | 3,554 | ||
| 2024-11-14 | John A. Ballantyne Revocable Living Trust dated 08/01/2017 10% owner | Other acquisition | +132,036 | $31.00 | $4.1M | 183,039 |
| 2024-11-14 | John A. Ballantyne Revocable Living Trust dated 08/01/2017 10% owner | Grant or award · Series A Common Warrant | +132,036 | 132,036 | ||
| 2024-11-14 | John A. Ballantyne Revocable Living Trust dated 08/01/2017 10% owner | Grant or award · Series B Common Warrant | +132,036 | 132,036 | ||
| 2024-11-14 | BALLANTYNE JOHN Director | Other acquisition | +132,036 | $31.00 | $4.1M | 183,039 |
| 2024-11-14 | BALLANTYNE JOHN Director | Grant or award · Series A Common Warrant | +132,036 | 132,036 | ||
| 2024-11-14 | BALLANTYNE JOHN Director | Grant or award · Series B Common Warrant | +132,036 | 132,036 | ||
| 2024-11-14 | Malave Luis Director | Conversion | +6,886 | $31.20 | $215K | 8,009 |
| 2024-11-14 | Malave Luis Director | Conversion · Convertible Promissory Note | −0 | $214,831.00 | $0 | 0 |
| 2024-11-14 | Malave Luis Director | Grant or award · Series A Common Warrant | +6,886 | 6,886 | ||
| 2024-11-14 | Malave Luis Director | Grant or award · Series B Common Warrant | +6,886 | 6,886 |
Page 2 of 6 · 115 trades